Security Snapshot

HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS) Institutional Ownership

CUSIP: 416196202

13F Institutional Holders and Ownership History from Q4 2015 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

22

Shares (Excl. Options)

2.08MFull value: 2,082,548 · shares · 30 Jun 2026

Price

$2.16

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $1.00 per share
Symbol
HHS on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
2,082,548
Latest holder snapshot 5 signals
Total 13F value
$4,497,753
Portfolio coverage rank
0%
Share change
+4,172
Value change
+$7,072
Number of holders
22
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
7,428,895
SEC-reported price per share
$4.46
Insider filing price
$4.46
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • HHS - HARTE HANKS INC - Common Stock, par value $1.00 per share is tracked under CUSIP 416196202.
  • 22 institutions reported positions in Q2 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 22 to 22 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $4.79MFull value: $4,788,142 · USD · 31 Mar 2026
    to
    $4.5MFull value: $4,497,753 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 22 institutions filings for Q2 2026.

Open SEC evidence

Security key

416196202

13F reference period

Q2 2026

13F holders

22

13D/G owners

3

CIK / CUSIP context first

Open Q2 2026 holders HHS full holder history HARTE HANKS INC SEC filings HARTE HANKS INC company facts HARTE HANKS INC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
HHS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rosenbach Gary Stephen 29% $9,639,789 2,118,635 Gary S. Rosenbach 17 Apr 2023
Radoff Bradley Louis 5.7% $914,646 423,447 Radoff Bradley Louis 14 Aug 2026
Kent Lake PR LLC 2.5% $897,411 180,203 Kent Lake PR LLC 31 Dec 2024
As of 30 Jun 2026, 22 institutional investors reported holding
2.08MFull value: 2,082,548 · shares · 30 Jun 2026
shares of HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS). This represents 28% of the company’s total
7.43MFull value: 7,428,895 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 23 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
28%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BLAIR WILLIAM & CO/IL 8.9% 660,845 0% 0% $1,427,425
WESTERLY CAPITAL MANAGEMENT, LLC 8.5% 635,000 +1.3% 0.25% $1,371,600
VANGUARD CAPITAL MANAGEMENT LLC 3.5% 259,036 0% 0% $559,518
Krilogy Financial LLC 2.1% 152,379 +29% 0.01% $329,139
RAFFLES ASSOCIATES LP 1.2% 87,757 0% 0.16% $189,555
GEODE CAPITAL MANAGEMENT, LLC 0.74% 54,988 -5% 0% $118,808
DIMENSIONAL FUND ADVISORS LP 0.57% 42,621 0% 0% $92,061
ACADIAN ASSET MANAGEMENT LLC 0.44% 32,478 -0.21% 0% $70,000
VANGUARD FIDUCIARY TRUST CO 0.41% 30,619 0% 0% $66,137
STATE STREET CORP 0.36% 26,497 0% 0% $57,234
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.35% 26,100 -20% 0% $56,376
RENAISSANCE TECHNOLOGIES LLC 0.29% 21,400 -3.6% 0% $46,224
BlackRock, Inc. 0.26% 19,028 -34% 0% $41,100
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.23% 17,204 0% 0% $37,161
LSV ASSET MANAGEMENT 0.17% 12,700 0% 0% $27,000
Vanguard Global Advisers, LLC 0.03% 1,918 0% 0% $4,143
Tower Research Capital LLC (TRC) 0.02% 1,725 -14% 0% $3,726
UBS Group AG 0% 152 -27% 0% $328
Triumph Capital Management 0% 86 0% 0% $186
MORGAN STANLEY 0% 12 +71% 0% $26
BARCLAYS PLC 0% 2 0% $4
WELLS FARGO & COMPANY/MN 0% 1 0% 0% $2
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0% 0 -100% $0

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
41
Headline period
Q2 2026
Rows shown
1-25 of 41
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 152,090 $664,648 -$1,639 $4.46 2
2026 Q2 2,082,548 $4,497,753 +$7,072 $2.16 22
2026 Q1 2,078,376 $4,788,142 +$3,776 $2.27 22
2025 Q4 2,076,132 $6,259,961 -$125,547 $3.01 23
2025 Q3 2,117,837 $7,770,288 -$471,768 $3.71 22
2025 Q2 2,239,999 $8,915,272 -$18,623 $3.98 23
2025 Q1 2,242,065 $10,760,915 -$869,931 $4.80 23
2024 Q4 2,410,425 $12,412,138 -$1,323,602 $5.15 23
2024 Q3 2,650,020 $19,731,218 -$1,811,108 $7.44 25
2024 Q2 2,560,223 $20,788,107 +$2,612,713 $8.12 30
2024 Q1 2,358,456 $17,639,492 -$542,274 $7.48 26
2023 Q4 2,433,546 $16,529,955 +$124,528 $6.79 26
2023 Q3 2,419,675 $15,751,446 -$2,367,715 $6.51 23
2023 Q2 2,825,760 $15,482,732 -$1,833,384 $5.48 30
2023 Q1 3,103,331 $29,200,550 -$1,452,853 $9.41 32
2022 Q4 3,207,842 $37,498,779 +$1,313,107 $11.69 40
2022 Q3 3,156,793 $35,220,000 +$9,452,042 $11.15 35
2022 Q2 2,305,041 $29,208,249 -$697,052 $12.74 17
2022 Q1 2,368,141 $17,927,000 -$1,205,317 $7.57 13
2021 Q4 2,515,646 $19,125,000 +$8,588,000 $7.60 9
2020 Q4 0 $0 -$460,412 $4.46 0
2020 Q3 221,723 $460,412 -$5,971,588 $2.08 5
2020 Q2 2,120,919 $6,448,000 -$281,207 $3.04 18
2020 Q1 2,213,794 $3,475,000 +$944,826 $1.57 18
2019 Q4 1,611,624 $5,769,000 +$34,300 $3.58 15
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .